| Baseline | 6 weeks follow-up |
---|
EPIC domain summary scores | EPIC domain summary scores |
---|
Urinary | Bowel | Sexual | Hormonal | Urinary | Bowel | Sexual | Hormonal |
---|
EORTC PR-25 |
Urinary symptoms |
−0.70
| | | |
−0.79
| | | |
Bowel symptoms | | −0.42 | | | |
−0.64
| | |
Hormonal treatment | | | |
−0.58
| | | |
−0.70
|
Sexual activity | | |
0.68
| | | | 0.14 | |
Sexual functioning | | |
0.66
| | | | 0.25 | |
Feeling Thermometerb | 0.12 | 0.18 | 0.06 |
0.37
|
0.37
| 0.28 | 0.27 |
0.50
|
SF-36 |
Physical Functioning |
0.40
| | | |
0.47
| | | |
Social Functioning | 0.14 | 0.13 | | |
0.49
| 0.19 | | |
Bodily Pain | | 0.22 | | | | 0.56 | | |
Role Emotional | | | 0.08 | 0.61 | | |
0.36
| 0.62 |
General Health | | | |
0.47
| | | | 0.59 |
Vitality | | | | 0.60 | | | | 0.72 |
- Abbreviations: EPIC Expanded Prostate Cancer Index Composite, EORTC PR25 European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire–Prostate 25; Hormonal treatment = Hormonal treatment-related symptoms
- aCorrelation coefficients according to distribution: Spearman’s rank correlation coefficients for not-normally distributed scores at baseline and 6 weeks follow-up. Correlation coefficients are boldface font when they met our assumptions and normal font when they were higher or lower than expected
- bMissing values: Correlations between EPIC and EORTC PR-25 domains: 3 to 13, except for EPIC sexual and EORTC PR25 sexual functioning domains (baseline = 23/follow-up = 57); Correlations between EPIC domains and Feeling Thermometer: baseline = 24–25/follow-up = 9–10; Correlations between EPIC and SF-36 domains: all time points = 0–2